ACI Formulations Statistics
Total Valuation
ACI Formulations has a market cap or net worth of BDT 5.75 billion. The enterprise value is 8.79 billion.
Market Cap | 5.75B |
Enterprise Value | 8.79B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
Earnings Date | Oct 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ACI Formulations has 47.25 million shares outstanding.
Shares Outstanding | 47.25M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 12.54% |
Owned by Institutions (%) | n/a |
Float | 16.06M |
Valuation Ratios
The trailing PE ratio is 20.31.
PE Ratio | 20.31 |
Forward PE | n/a |
PS Ratio | 1.16 |
PB Ratio | 1.78 |
P/FCF Ratio | 7.13 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.18, with an EV/FCF ratio of 10.90.
EV / Earnings | 31.06 |
EV / Sales | 1.77 |
EV / EBITDA | 15.18 |
EV / EBIT | 16.47 |
EV / FCF | 10.90 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.97.
Current Ratio | 1.24 |
Quick Ratio | 0.89 |
Debt / Equity | 0.97 |
Debt / EBITDA | 5.43 |
Debt / FCF | 3.90 |
Interest Coverage | 2.03 |
Financial Efficiency
Return on equity (ROE) is 8.73% and return on invested capital (ROIC) is 5.19%.
Return on Equity (ROE) | 8.73% |
Return on Assets (ROA) | 4.58% |
Return on Capital (ROIC) | 5.19% |
Revenue Per Employee | 5.05M |
Profits Per Employee | 287,412 |
Employee Count | 985 |
Asset Turnover | 0.68 |
Inventory Turnover | 2.39 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.48% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -21.48% |
50-Day Moving Average | 134.84 |
200-Day Moving Average | 135.15 |
Relative Strength Index (RSI) | 30.56 |
Average Volume (20 Days) | 24,153 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ACI Formulations had revenue of BDT 4.97 billion and earned 283.10 million in profits. Earnings per share was 5.99.
Revenue | 4.97B |
Gross Profit | 1.38B |
Operating Income | 533.85M |
Pretax Income | 372.03M |
Net Income | 283.10M |
EBITDA | 579.30M |
EBIT | 533.85M |
Earnings Per Share (EPS) | 5.99 |
Balance Sheet
The company has 104.55 million in cash and 3.14 billion in debt, giving a net cash position of -3.04 billion or -64.33 per share.
Cash & Cash Equivalents | 104.55M |
Total Debt | 3.14B |
Net Cash | -3.04B |
Net Cash Per Share | -64.33 |
Equity (Book Value) | 3.24B |
Book Value Per Share | 68.45 |
Working Capital | 920.94M |
Cash Flow
In the last 12 months, operating cash flow was 953.44 million and capital expenditures -146.54 million, giving a free cash flow of 806.90 million.
Operating Cash Flow | 953.44M |
Capital Expenditures | -146.54M |
Free Cash Flow | 806.90M |
FCF Per Share | 17.08 |
Margins
Gross margin is 27.72%, with operating and profit margins of 10.73% and 5.69%.
Gross Margin | 27.72% |
Operating Margin | 10.73% |
Pretax Margin | 7.48% |
Profit Margin | 5.69% |
EBITDA Margin | 11.64% |
EBIT Margin | 10.73% |
FCF Margin | 16.22% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 2.05%.
Dividend Per Share | 2.50 |
Dividend Yield | 2.05% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 39.30% |
Buyback Yield | n/a |
Shareholder Yield | 2.05% |
Earnings Yield | 4.92% |
FCF Yield | 14.03% |
Stock Splits
The last stock split was on November 21, 2021. It was a forward split with a ratio of 1.05.
Last Split Date | Nov 21, 2021 |
Split Type | Forward |
Split Ratio | 1.05 |
Scores
ACI Formulations has an Altman Z-Score of 2.38. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.38 |
Piotroski F-Score | n/a |